1Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea
2Department of Public Health, Korea University Graduate School, Seoul, Korea
3Department of Health Policy and Management, Korea University Graduate School, Seoul, Korea
4Transdisciplinary Major in Learning Health Systems, Department of Healthcare Sciences, Korea University Graduate School, Seoul, Korea
5Graduate School of Public Health, Korea University, Seoul, Korea
6Center for Labour and Health, People’s Health Institute, Seoul, Korea
Copyright © 2023 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
The authors have no conflicts of interest associated with the material presented in this paper.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: Kang M, Yu S, Choe SA, Moon D, Ki M, Chun BC. Data curation: Kang M, Choe SA, Chun BC. Formal analysis: Kang M, Choe SA, Chun BC. Funding acquisition: None. Methodology: Kang M, Choe SA, Chun BC. Project administration: None. Visualization: Kang M, Choe SA, Chun BC. Writing – original draft: Kang M, Yu S, Choe SA. Writing – review & editing: Kang M, Yu S, Choe SA, Moon D, Ki M, Chun BC.
Values are presented as number (%) or relative risk (95% confidence interval); All percentages are weighted to account for the sample design and ensure representative results.
COVID-19, coronavirus disease 2019.
1 Adjusted for age, income, education, employment, year, marital status, and presence of children.
Regions2 | Age (y) | |||||||
---|---|---|---|---|---|---|---|---|
|
||||||||
30–34 | p for heterogeneity | 35–39 | p for heterogeneity | 40–44 | p for heterogeneity | 45–49 | p for heterogeneity | |
Urban | ||||||||
2017–2019 (pre–COVID-19) | ||||||||
Gender | <0.001 | <0.001 | <0.001 | |||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.06 (1.02, 1.10) | 1.01 (0.97, 1.05) | 0.90 (0.87, 0.93) | 0.86 (0.83, 0.90) | ||||
2020 (early pandemic) | ||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.16 (1.08, 1.25) | 1.10 (1.03, 1.17) | 0.98 (0.92, 1.05) | 0.85 (0.80, 0.91) | ||||
2021 (post-vaccination) | ||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.22 (1.14, 1.31) | 1.13 (1.06, 1.20) | 0.99 (0.93, 1.05) | 0.99 (0.93, 1.06) | ||||
|
||||||||
Rural | ||||||||
2017–2019 (pre–COVID-19) | ||||||||
Gender | 0.753 | 0.993 | 0.918 | 0.147 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.20 (1.08, 1.33) | 1.03 (0.95, 1.12) | 0.94 (0.87, 1.02) | 0.95 (0.88, 1.03) | ||||
2020 (early pandemic) | ||||||||
Gender | 0.753 | 0.993 | 0.918 | 0.147 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.12 (0.93, 1.34) | 1.05 (0.91, 1.21) | 0.97 (0.84, 1.12) | 1.04 (0.92, 1.18) | ||||
2021 (post-vaccination) | ||||||||
Gender | 0.753 | 0.993 | 0.918 | 0.147 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.02 (0.86, 1.21) | 0.95 (0.81, 1.10) | 0.94 (0.82, 1.07) | 1.00 (0.88, 1.13) |
Values are presented as relative risk (95% confidence interval).
COVID-19, coronavirus disease 2019.
1 Adjusted for age, income, education, employment, year, marital status, and presence of children.
2 Cities within metropolitan, special, autonomous, and provincial cities were categorized as urban, while counties were classified as rural based on geocodes in the data.
Characteristics | Men | Women | ||||
---|---|---|---|---|---|---|
|
| |||||
Period | Period | |||||
|
| |||||
Pre–COVID-19 (2017–2019) | Early pandemic (2020) | Post-vaccination (2021) | Pre–COVID-19 (2017–2019) | Early pandemic (2020) | Post-vaccination (2021) | |
Age (y) | ||||||
30–34 | 16 967 (20.0) | 5225 (20.1) | 5624 (21.2) | 18 799 (19.4) | 5552 (19.3) | 5838 (19.9) |
35–39 | 22 908 (26.1) | 6920 (25.8) | 6818 (24.3) | 26 149 (26.3) | 7594 (25.8) | 7452 (24.9) |
40–44 | 24 210 (25.1) | 7713 (25.1) | 7843 (26.2) | 27 442 (24.7) | 8498 (24.7) | 8811 (26.1) |
45–49 | 28 360 (28.8) | 9230 (29.0) | 9004 (28.2) | 32 276 (29.5) | 10 481 (30.2) | 9878 (29.1) |
| ||||||
Income | ||||||
Q4 (highest) | 25 467 (31.7) | 8482 (32.4) | 9986 (37.9) | 27 960 (31.0) | 8733 (30.7) | 10 171 (35.3) |
Q3 | 26 820 (30.5) | 9534 (33.5) | 7416 (25.5) | 29 434 (29.5) | 10 878 (34.7) | 8232 (26.3) |
Q2 | 26 293 (27.2) | 6517 (21.5) | 7825 (25.6) | 30 816 (28.2) | 7386 (21.9) | 8880 (26.3) |
Q1 (lowest) | 12 213 (10.6) | 4319 (12.6) | 3942 (11.0) | 14 507 (11.3) | 4819 (12.7) | 4550 (12.1) |
| ||||||
Education | ||||||
Primary | 547 (0.5) | 153 (0.5) | 125 (0.3) | 799 (0.5) | 224 (0.5) | 190 (0.4) |
Secondary | 35 163 (33.9) | 10 755 (32.7) | 10 100 (30.5) | 42 911 (36.3) | 12 352 (33.7) | 11 103 (30.2) |
College or above | 56 656 (65.6) | 18 163 (66.8) | 19 055 (69.2) | 60 880 (63.2) | 19 520 (65.8) | 20 681 (69.4) |
| ||||||
Employment status | ||||||
Business owner or self-employed | 21 180 (20.5) | 6196 (18.9) | 6230 (19.0) | 12 206 (10.8) | 3552 (10.4) | 3838 (11.4) |
Employee | 65 205 (73.6) | 20 197 (72.6) | 20 740 (73.6) | 52 127 (49.9) | 16 195 (50.1) | 16 749 (52.2) |
Unpaid family worker | 991 (0.5) | 349 (0.7) | 287 (0.5) | 3799 (2.0) | 944 (1.6) | 868 (1.4) |
Others | 5069 (5.3) | 2346 (7.8) | 2032 (6.8) | 36 534 (37.4) | 11 434 (38.0) | 10 524 (35.0) |
| ||||||
Marital status | ||||||
Married, living with a spouse | 65 293 (71.8) | 18 722 (65.7) | 18 898 (66.5) | 84 747 (81.0) | 24 188 (75.3) | 24 061 (75.3) |
Others | 27 075 (28.2) | 10 352 (34.3) | 10 388 (33.5) | 19 770 (19.0) | 7920 (24.7) | 7915 (24.7) |
| ||||||
Children | ||||||
0 | 38 909 (40.9) | 13 559 (45.6) | 13 924 (46.2) | 30 134 (27.4) | 10 334 (31.1) | 10 720 (32.8) |
≥1 | 53 438 (59.1) | 15 515 (54.4) | 15 362 (53.8) | 74 369 (72.6) | 21 773 (68.9) | 21 256 (67.2) |
| ||||||
Psychosocial stress | ||||||
No | 63 950 (67.8) | 20 034 (68.2) | 20 395 (69.9) | 75 075 (69.5) | 22 127 (67.0) | 22 048 (67.9) |
Yes | 28 495 (32.2) | 9054 (32.8) | 8894 (31.1) | 29 591 (28.5) | 9998 (33.0) | 9931 (32.1) |
| ||||||
Total | 92 449 (100) | 29 088 (100) | 29 289 (100) | 104 666 (100) | 32 125 (100) | 31 979 (100) |
Period | n (weighted %) | RR (95% CI) | p for heterogeneity |
---|---|---|---|
2017–2019 (pre–COVID-19) | |||
Gender | <0.001 | ||
Men | 28 495 (32.9) | 1.00 (reference) | |
Women | 29 591 (28.5) | 0.95 (0.94, 0.97) | |
| |||
2020 (early pandemic) | |||
Gender | <0.001 | ||
Men | 9054 (33.5) | 1.00 (reference) | |
Women | 9998 (32.2) | 1.01 (0.98, 1.05) | |
| |||
2021 (post-vaccination) | |||
Gender | <0.001 | ||
Men | 8894 (31.8) | 1.00 (reference) | |
Women | 9931 (31.4) | 1.07 (1.04, 1.10) |
Period | Age (y) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
30–34 | p for heterogeneity | 35–39 | p for heterogeneity | 40–44 | p for heterogeneity | 45–49 | p for heterogeneity | |||||
2017–2019 (pre–COVID-19) | ||||||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||
Men | 5371 (32.6) | 1.00 (reference) | 7411 (33.6) | 1.00 (reference) | 7601 (32.9) | 1.00 (reference) | 8112 (30.0) | 1.00 (reference) | ||||
Women | 6150 (33.2) | 1.07 (1.03, 1.11) | 8027 (31.6) | 1.01 (0.98, 1.05) | 7532 (28.4) | 0.90 (0.87, 0.94) | 7882 (24.8) | 0.87 (0.84, 0.90) | ||||
| ||||||||||||
2020 (early pandemic) | ||||||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||
Men | 1631 (31.6) | 1.00 (reference) | 2264 (34.0) | 1.00 (reference) | 2425 (33.3) | 1.00 (reference) | 2734 (32.0) | 1.00 (reference) | ||||
Women | 1916 (36.2) | 1.16 (1.09, 1.25) | 2690 (37.4) | 1.10 (1.03, 1.16) | 2571 (32.4) | 0.98 (0.92, 1.05) | 2821 (27.5) | 0.86 (0.81, 0.92) | ||||
| ||||||||||||
2021 (post-vaccination) | ||||||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||
Men | 1690 (30.5) | 1.00 (reference) | 2214 (33.3) | 1.00 (reference) | 2456 (32.0) | 1.00 (reference) | 2534 (28.6) | 1.00 (reference) | ||||
Women | 2032 (35.7) | 1.21 (1.13, 1.29) | 2596 (35.6) | 1.13 (1.06, 1.20) | 2679 (31.3) | 0.99 (0.93, 1.05) | 2624 (27.5) | 0.99 (0.93, 1.06) |
Regions |
Age (y) | |||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
30–34 | p for heterogeneity | 35–39 | p for heterogeneity | 40–44 | p for heterogeneity | 45–49 | p for heterogeneity | |
Urban | ||||||||
2017–2019 (pre–COVID-19) | ||||||||
Gender | <0.001 | <0.001 | <0.001 | |||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.06 (1.02, 1.10) | 1.01 (0.97, 1.05) | 0.90 (0.87, 0.93) | 0.86 (0.83, 0.90) | ||||
2020 (early pandemic) | ||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.16 (1.08, 1.25) | 1.10 (1.03, 1.17) | 0.98 (0.92, 1.05) | 0.85 (0.80, 0.91) | ||||
2021 (post-vaccination) | ||||||||
Gender | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.22 (1.14, 1.31) | 1.13 (1.06, 1.20) | 0.99 (0.93, 1.05) | 0.99 (0.93, 1.06) | ||||
| ||||||||
Rural | ||||||||
2017–2019 (pre–COVID-19) | ||||||||
Gender | 0.753 | 0.993 | 0.918 | 0.147 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.20 (1.08, 1.33) | 1.03 (0.95, 1.12) | 0.94 (0.87, 1.02) | 0.95 (0.88, 1.03) | ||||
2020 (early pandemic) | ||||||||
Gender | 0.753 | 0.993 | 0.918 | 0.147 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.12 (0.93, 1.34) | 1.05 (0.91, 1.21) | 0.97 (0.84, 1.12) | 1.04 (0.92, 1.18) | ||||
2021 (post-vaccination) | ||||||||
Gender | 0.753 | 0.993 | 0.918 | 0.147 | ||||
Men | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
Women | 1.02 (0.86, 1.21) | 0.95 (0.81, 1.10) | 0.94 (0.82, 1.07) | 1.00 (0.88, 1.13) |
Values are presented as number (%). COVID-19, coronavirus disease 2019; Q, quartile. The total may not equal the sum of the column due to missing values of each characteristic.
COVID-19, coronavirus disease 2019; RR, relative risk; CI, confidence interval. Adjusted for age, income, education, employment, year, marital status, and presence of children.
Values are presented as number (%) or relative risk (95% confidence interval); All percentages are weighted to account for the sample design and ensure representative results. COVID-19, coronavirus disease 2019. Adjusted for age, income, education, employment, year, marital status, and presence of children.
Values are presented as relative risk (95% confidence interval). COVID-19, coronavirus disease 2019. Adjusted for age, income, education, employment, year, marital status, and presence of children. Cities within metropolitan, special, autonomous, and provincial cities were categorized as urban, while counties were classified as rural based on geocodes in the data.